P25. Characteristics, treatment options, and predictors of clinical failure among Pseudomonas aeruginosa infection with microbiologically confirmed intermediate or resistant carbapenem susceptibility profile: a multicenter clinical experience on behalf of CASPER (CArbapenem-reSistant <i>Pseudomonas aERuginosa</i> during and after the COVID-19 pandemic) study groupAndrea Dessilani, Marianna Meschiari, Gabriella Orlando et al.|JAC-Antimicrobial Resistance|2025Cited by 0